[{"Assets_0_Q1_USD":324726000.0,"CommonStockSharesOutstanding_0_Q1_shares":46307000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-70200000.0,"NetIncomeLoss_1_Q1_USD":-66257000.0,"StockholdersEquity_0_Q1_USD":283934000.0,"Ticker":"ATRA","CIK":"1604464","name":"ATARA BIOTHERAPEUTICS, INC.","OfficialName":"Atara Biotherapeutics Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"734540687.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190509"}]